These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Imidazo[1,2-a]pyridines. I. Synthesis and inotropic activity of new 5-imidazo[1,2-a]pyridinyl-2(1H)-pyridinone derivatives. Yamanaka M; Miyake K; Suda S; Ohhara H; Ogawa T Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1556-67. PubMed ID: 1934178 [TBL] [Abstract][Full Text] [Related]
4. Inotropic "A" ring substituted sulmazole and isomazole analogues. Barraclough P; Black JW; Cambridge D; Collard D; Firmin D; Gerskowitch VP; Glen RC; Giles H; Hill AP; Hull RA J Med Chem; 1990 Aug; 33(8):2231-9. PubMed ID: 2165165 [TBL] [Abstract][Full Text] [Related]
5. Inotropic activities of imidazopyridines. Barraclough P; Black JW; Cambridge D; Gerskowitch VP; Hull RA; Lyer R; King WR; Kneen CO; Nobbs MS; Shah GP Arch Pharm (Weinheim); 1990 Aug; 323(8):501-5. PubMed ID: 2278516 [TBL] [Abstract][Full Text] [Related]
6. Imidazopyridines: roles of pyridine nitrogen position and methylsulfinyl oxygen for in vitro positive inotropic mechanism and chronotropic activity. Honerjäger P; Klockow M; Schönsteiner G; Jonas R J Cardiovasc Pharmacol; 1989 May; 13(5):673-81. PubMed ID: 2472514 [TBL] [Abstract][Full Text] [Related]
7. Imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyrazines: the role of nitrogen position in inotropic activity. Spitzer WA; Victor F; Pollock GD; Hayes JS J Med Chem; 1988 Aug; 31(8):1590-5. PubMed ID: 3397997 [TBL] [Abstract][Full Text] [Related]
8. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS. Diederen W; Kadatz R Arzneimittelforschung; 1981; 31(1a):141-6. PubMed ID: 7195207 [TBL] [Abstract][Full Text] [Related]
9. The response of the calcium dependent myocardial contractility to the new cardiotonic agent sulmazole. Achenbach C; Ziskoven R; Wiemer J; Hauswirth O Arzneimittelforschung; 1984; 34(11):1498-506. PubMed ID: 6543125 [TBL] [Abstract][Full Text] [Related]
10. Cardiotonic agents. 5. 1,2-Dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-6-methyl-2-oxo-3- pyridinecarbonitriles and related compounds. Synthesis and inotropic activity. Sircar I; Duell BL; Bristol JA; Weishaar RE; Evans DB J Med Chem; 1987 Jun; 30(6):1023-9. PubMed ID: 3585900 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043. Endoh M; Yanagisawa T; Morita T; Taira N J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507 [TBL] [Abstract][Full Text] [Related]
12. Imidazole-pyridine bioisosterism: comparison of the inotropic activities of pyridine- and imidazole-substituted 6-phenyldihydropyridazinone cardiotonics. Robertson DW; Krushinski JH; Pollock GD; Hayes JS J Med Chem; 1988 Feb; 31(2):461-5. PubMed ID: 3339616 [TBL] [Abstract][Full Text] [Related]
13. In vivo cardiotonic activity of aryl- and pyridyl-substituted fused imidazoles. Andreani A; Leoni A; Morigi R; Bossa R; Chiericozzi M; Galatulas I Arzneimittelforschung; 1998 Mar; 48(3):232-5. PubMed ID: 9553678 [TBL] [Abstract][Full Text] [Related]
14. Effect of sulmazole and pimobendan on contractility of skinned fibres from frog skeletal muscle. Piazzesi G; Morano I; Rüegg JC Arzneimittelforschung; 1987 Oct; 37(10):1141-3. PubMed ID: 3435586 [TBL] [Abstract][Full Text] [Related]
15. A novel class of cardiotonics. Synthesis and pharmacological properties of [4-(substituted-amino)phenyl]pyridazinones and related derivatives. Okushima H; Narimatsu A; Kobayashi M; Furuya R; Tsuda K; Kitada Y J Med Chem; 1987 Jul; 30(7):1157-61. PubMed ID: 3599022 [TBL] [Abstract][Full Text] [Related]
16. Imidazo[1,2-alpha]pyridines. II. Ozonolysis of imidazo[1,2-alpha]pyridines and synthesis of cardiotonic agents. Yamanaka M; Suda S; Yoneda N; Ohhara H Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):666-74. PubMed ID: 1611679 [No Abstract] [Full Text] [Related]
17. Sulmazole effects on mechanical performance of hypoxic and reoxygenated isolated mammalian myocardium. Bonoron-Adèle S; Grellet J; Bricaud H; Tariosse L; Besse P Arzneimittelforschung; 1986 Nov; 36(11):1572-7. PubMed ID: 3814219 [TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal cardiotonics. 3. New 4,5-dihydro-6-(1H-indol-5-yl)pyridazin-3(2H)-ones and related compounds with positive inotropic activities. Mertens A; Friebe WG; Müller-Beckmann B; Kampe W; Kling L; von der Saal W J Med Chem; 1990 Oct; 33(10):2870-5. PubMed ID: 2213839 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and cardiotonic activity of certain imidazo[2,1-b]-1,3,4-thiadiazole derivatives. el-Sherbeny MA; el-Bendary ER; el-Subbagh HI; el-Kashef HA Boll Chim Farm; 1997 Mar; 136(3):253-6. PubMed ID: 9164165 [TBL] [Abstract][Full Text] [Related]
20. Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS. Kutter E; Austel V Arzneimittelforschung; 1981; 31(1a):135-41. PubMed ID: 7195206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]